Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3044923

The cost-effectiveness of hypertension treatment in Sweden : an analysis of the criteria for intervention and the choice of drug treatment

Author
JOHANNESSON, M1
[1] Centre for Health Economics, Stockholm School of Economics, Box 6501, 113 83 Stockholm, Sweden
Conference title
Hypertension control : economics and lifestyle issues
Conference name
Official Symposia of the World Conference on Hypertension Control (Ottawa 1995-06-21)
Author (monograph)
CHOCKALINGAM, Arun (Editor)1 ; FODOR, George (Author of introductory parts); HAMET, Pavel (Author of introductory parts)
World Hypertension League, International (Funder/Sponsor)
Canadian Coalition for High Blood Pressure Prevention and Control, Canada (Funder/Sponsor)
[1] Disease Prevention Division, Health Promotion and Programs Branch, Health Canada, Room 512, Jeanne Mance Building, Tunney's Pasture, Ottawa, Ontario K1A 1B4, Canada
Source

Journal of human hypertension. 1996, Vol 10, pp S23-S26 ; SUP2 ; ref : 13 ref

ISSN
0950-9240
Scientific domain
Cardiology, blood circulation, phlebology
Publisher
Nature Publishing, Basingstoke
Publication country
United Kingdom
Document type
Conference Paper
Language
English
Keyword (fr)
Analyse coût efficacité Antagoniste calcium Antihypertenseur Chimiothérapie Economie santé Homme Hypertension artérielle Inhibiteur enzyme Peptidyl-dipeptidase A Traitement Angiotensin converting enzyme Suède Appareil circulatoire pathologie Enzyme Hydrolases Peptidyl-dipeptidases Proteinases Santé publique Europe
Keyword (en)
Cost efficiency analysis Calcium antagonist Antihypertensive agent Chemotherapy Health economy Human Hypertension Enzyme inhibitor Peptidyl-dipeptidase A Treatment Sweden Cardiovascular disease Enzyme Hydrolases Peptidyl-dipeptidases Proteinases Public health Europe
Keyword (es)
Análisis costo eficacia Antagonista calcio Antihipertensivo Quimioterapia Economía salud Hombre Hipertensión arterial Inhibidor enzima Peptidyl-dipeptidase A Tratamiento Suecia Aparato circulatorio patología Enzima Hydrolases Peptidyl-dipeptidases Proteinases Salud pública Europa
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F05 Antihypertensive agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
3044923

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Searching the Web